Age in years |
Number |
Percentage |
36-40 |
45 |
21.0 |
41-45 |
52 |
24.3 |
46-50 |
95 |
44.4 |
51-55 |
10 |
4.7 |
56-60 |
8 |
3.7 |
>60 |
4 |
1.9 |
Total |
214 |
100 |
Parity |
Number |
Percentage |
Para
1 |
16 |
7.5 |
Para
2 |
148 |
69.2 |
Para
3 and above |
45 |
21 |
Nulliparous |
5 |
2.3 |
Total |
214 |
100 |
Symptom |
Number |
Percentage |
Heavy
menstrual bleeding |
52 |
24.3 |
Irregular
menstrual bleeding |
40 |
18.7 |
Absent
menstrual bleeding |
0 |
0 |
Frequent
menstrual bleeding |
36 |
16.8 |
Infrequent
menstrual bleeding |
4 |
1.9 |
Prolonged
menstrual bleeding |
30 |
14.0 |
Heavy
and prolonged menstrual bleeding |
35 |
16.4 |
Shortened
mentrual bleeding |
0 |
0 |
Postmenopausal
bleeding |
9 |
4.2 |
Irregular
nonmenstrual bleeding |
8 |
3.7 |
Total |
214 |
100 |
Preoperative
diagnosis |
Number |
Percentage |
Fibroids |
74 |
34.6 |
Adenomyosis |
36 |
16.8 |
Ovulatory disorder |
51 |
23.8 |
Chronic PID |
11 |
5.1 |
Endometriosis |
25 |
11.7 |
Cervical dysplasia |
10 |
4.7 |
Cervical polyp |
3 |
1.4 |
Carcinoma cervix |
2 |
0.9 |
Carcinoma endometrium |
2 |
0.9 |
Total |
214 |
100 |
|
Histopathological
diagnosis |
Number |
Percentage |
P |
Polyp(AUB-P) |
3 |
1.4 |
A |
Adenomyosis(AUB-A) |
46 |
21.5 |
L |
Leiomyoma(AUB-L) |
82 |
38.3 |
M |
Malignancies And
Hyperplasias (AUB-M) |
9 |
4.2 |
C |
Coagulopathy (AUB-C) |
0 |
0 |
O |
Ovulatory Disorder(AUB-O) |
47 |
22.0 |
I |
Iatrogenic(AUB-I) |
0 |
0 |
E |
Endometrial (AUB-E) |
27 |
12.6 |
N |
Not Classified(AUB-N) |
0 |
0 |
|
TOTAL |
214 |
100 |
Age
group |
36-40 |
41-45 |
46-50 |
51-55 |
56-60 |
>60 |
Total |
Polyp(AUB-P) |
|
2 (66.7%) |
1 (33.3%) |
|
|
|
3 |
Adenomyosis (AUB-A) |
8 (17.4%) |
15 (32.6%) |
18 (39.1%) |
5 (10.9%) |
|
|
46 |
Leiomyoma (AUB-L) |
20 (24.4%) |
31 (37.8%) |
25 (30.5%) |
6 (7.3%) |
|
|
82 |
Malignancies Hyperplasia (AUB-M) |
|
|
2 (22.2%) |
1 (11.1%) |
2 (22.2%) |
4 (44.4%) |
9 |
Coagulopathy(AUB-C) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ovulatory Disorder (AUB-O) |
2 (4.3%) |
20 (42.6%) |
25 (53.2%) |
|
|
|
47 |
Iatrogenic (AUB-I) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Endometrial(AUB-E) |
|
4 (14.8%) |
18 (66.7%) |
5 (18.5%) |
|
|
27 |
Not Classified (AUB-N) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Total |
30 |
72 |
89 |
17 |
2 |
4 |
214 |